
9.84BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US5011471027
CUSIP
501147102
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
41.64
PEG Ratio
-
Book Value
45.92
Dividend Share
-
Dividend Yield
-
Earnings Share
7.98
Wall Street Target Price
395.44
EPS Estimate Current Year
7.59
EPS Estimate Next Year
8.95
EPS Estimate Current Quarter
1.9144
EPS Estimate Next Quarter
2.1627
Most Recent Quarter
-
Revenue TTM
440,484,000
Gross Profit TTM
416,868,000
EBITDA
199,292,992
Profit Margin
54.82%
Return On Assets TTM
9.37%
Return On Equity TTM
20.12%
Revenue Per Share TTM
15.076
Qtly Revenue Growth YOY
24.10%
Diluted Eps TTM
7.98
Qtly Earnings Growth YOY
38.80%
Trailing PE
41.64
Forward PE
47
Price Sales TTM
22.3286
Price Book MRQ
7.244
Enterprise Value Revenue
20
Enterprise Value EBITDA
44
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%